Cargando...
Have adjuvant tyrosine kinase inhibitors lost their shine?
Despite broad advances in molecularly targeted therapies, lung cancer remains the leading cause of cancer related mortality in the United States. Epidermal growth factor receptor (EGFR) mutations occur in approximately 17% of advanced non-small cell lung cancer (NSCLC) in the US population. The rema...
Gardado en:
| Publicado en: | Ann Transl Med |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
AME Publishing Company
2016
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4980379/ https://ncbi.nlm.nih.gov/pubmed/27568486 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2016.07.18 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|